Root Financial Partners
UNCY icon

Root Financial Partners’s Unicycive Therapeutics UNCY Stock Holding History

Root Financial Partners’s Portfolio UNCY Stock Details UNCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$380 Buy
+81
New +$420 ﹤0.01% 3331

Other funds holding UNCY

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Fortitude Family Office
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Essential Partners
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Root Financial Partners's UNCY Position: Q3 2026 in Review

Root Financial Partners opened a new position in Unicycive Therapeutics (UNCY) in Q3 2026: 81 shares worth $380. The stake represents ﹤0.01% of the portfolio and ranks #3331 among its holdings.

9 funds tracked by Wall St. Rank hold UNCY as of Q3 2026.

  • Root Financial Partners held 81 shares of Unicycive Therapeutics worth $380 as of Q3 2026.
  • Unicycive Therapeutics was a new Root Financial Partners position in Q3 2026.
  • Unicycive Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3331 holding.
  • 9 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.